It notes that research settings can track drug levels using mass spectrometry or isotope labelling, but says those methods are not available in typical outpatient care
Key Considerations Compounded semaglutide is not equivalent to FDA-approved semaglutide products Safety, efficacy, and quality may vary among compounded formulations Use requires medical supervision and ongoing monitoring Cost, availability, and formulation differ depending on the pharmacy and prescription Patients should discuss FDA-approved options, compounded alternatives, potential risks, and expected outcomes with their healthcare provider before starting treatment
Most people do fine, but some may experience mild digestive issues such as nausea or vomiting
For people with complex medical histories, multiple comorbidities, or who value extensive personalized support, a brick-and-mortar obesity medicine clinic may be more appropriate despite higher costs and less convenience
Semaglutide for managing overweight and obesity Recommendations
GIPR: glucose-dependent insulinotropic polypeptide receptor